Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital.
The Latest Bing News on:
Memorial Sloan-Kettering Cancer Center (MSKCC) Research
- Dr. Kosj Yamoah: The Ghanaian bridging healthcare disparities, and advocating for cancer families
Dr. Kosj Yamoah is an accomplished medical professional and researcher, currently holding the position of Chairman of the Department of Radiation Oncology and Chief of Genitourinary Radiation Oncology ...
- Stop & Shop Fights Pediatric Cancer with Kick Off of ‘Help Cure Childhood Cancer’ Campaign
Campaign, Which Has Hit a Milestone of Over $110 Million Raised, Will Continue to Support Pediatric Cancer Research and Care at Dana-Farber Cancer Institute and MSK Kids, the Pediatric Program at ...
- Full Approval ‘Validates’ Promise of Tepmetko for Lung Cancer Subset
After Tepmetko’s full approval for metastatic lung cancer treatment, patients should feel that the data from the accelerated approval is validated, an expert said.
- Battling Prostate Cancer and the Fight for More Awareness
Lamont Mitchell, chair of the Anacostia Coordinating Council, fights prostate cancer while raising awareness about the importance of early detection and second opinions in the African American ...
- First, a Cancer Diagnosis. Then a Split-Second Decision About Fertility.
Young women who find out they have breast cancer often have a very short window to make lifelong decisions about their futures.
The Latest Bing News on:
Memorial Sloan-Kettering Cancer Center (MSKCC) Discovery
- Sloan Museum of Discovery awarded $350,000 grant for STEM program
Sloan also offers hundreds of STEM programs through libraries, partner schools, summer camps, scouts, and free drop in classes.
- Curadev Announces First Treatment Cycle Completion for the First Patient Dosed in a Phase 1a/b Clinical Trial of Allosteric STING Agonist CRD3874-SI
India], February 29: Curadev, a drug discovery and development company, announced today a significant milestone in its development of drugs targeting the immune system to treat cancer. The dosing of ...
- Cervical cancer deaths could be reduced with home HPV testing, study finds
Nicole B. Saphier, M.D. — associate professor at Memorial Sloan Kettering Cancer Center in New York City, director of breast imaging at Memorial Sloan Kettering in Monmouth, New Jersey ...
- Curadev's Differentiated Next Generation STING Agonist CRD3874-SI
These features of CRD3874-SI predict a high therapeutic index in humans and support clinical investigation of this agent in cancer patients. The poster was co-authored by Dr. Ciara Kelly, MD, Memorial ...
- Can Exercise Help Prevent Prostate Cancer?
Iyengar, a medical oncologist and physician scientist at Memorial Sloan Kettering Cancer Center in New York City who was not involved in the study. “It also helps to improve the population of ...